Test Details: Flow cytometry MRD is done in known case of AML, B-ALL, T-ALL, Multiple myeloma or CLPD on therapy. Used to assess whether there is residual disease present or not at definite stages of therapy. Markers for MRD assessment is chosen on the basis of expression of markers at the time of diagnosis.